![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
RNA LAUNCH SYSTEM ENABLES IN VITRO EVALUATION OF BEPIROVIRSEN EFFICACY AGAINST HBV VARIANTS
|
|
|
AASLD 2022 Nov 4-8
Yingpu Yu2*, Alexander Koenig1*, Christine Livingston1, Hardeep van
Gijzel4, Rob Elston3, Dickens Theodore3, Melanie T. Paff3, Charles M. Rice2,
Shihyun You1, William M. Schneider2*
1GSK, Upper Providence, PA, USA, Infectious Diseases Research Unit; 2The Rockefeller University, NY, USA, Laboratory of Virology and Infectious Disease; 3GSK, Upper Providence, PA, USA, Clinical Development; 4 GSK, Upper Providence, PA, USA, Human Genetics Computational Biology; *Contributes equally, Presenter
![1110221](../images/111022/111022-10/1110221.gif)
![1110222](../images/111022/111022-10/1110222.gif)
![1110223](../images/111022/111022-10/1110223.gif)
![1110224](../images/111022/111022-10/1110224.gif)
![1110225](../images/111022/111022-10/1110225.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|